Canonico, A.E. et al., "Expression of a CMV Promoter Driven Human .alpha.-1 Antitrypsin Gene in Cultured Lung Endothelial Cells and in the Lungs of Rabbits," Clin. Res., 39(2): 219A (1991). |
Ledley, F.D., "Non-viral gene therapy," Current Opinion in Biotechnology, 5: 626-636 (1994). |
Ledley, F.D., "Nonviral Gene Therapy: The Promise of Genes as Pharmaceutical Products," Human Gene Therapy, 6: 1129-1144 (Sep., 1995). |
Rosenfeld, M.A. et al., "Adenovirus-Mediated Transfer of a Recombinant .alpha.1-Antitrypsin Gene to the Lung Epithelium in Vivo," Science, 252: 431-434 (Apr. 19, 1991). |
Marshall, E., "Gene Therapy's Growing Pains," Science, 269: 1050-1055 (Aug. 25, 1995). |
Alton, E.W.F.W. et al., "Noninvasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice," Chemical Abstracts, 119(21):62 (Nov. 22, 1993) (Absract 217089w). |
Flotte, T.R., et al., "Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector," Chemical Abstracts, 120(5):229 (Jan. 31, 1994) (Abstract 46918e). |
Textbook of Respiratory Medicine, John F. Murray, ed., W.B. Saunders Company, Harcourt Brace Jovanovich, Inc., Philadelphia, PA, p. 1038 (1988). |
Klein, J.O. Clinical Infectious Diseases, vol. 19, pp. 823-833, 1994. |
Berman, S. Pediatrics, vol. 96, No. 1, pp. 126-131, Jul. 1995. |
Karver Ear, Nose and Throat disorders, vol. 25, No. 3, pp. 619-632, Sep. 1998. |
Baker, Pediatric Annals, vol. 20, No. 11, pp. 591-593, 596-598, Nov. 1991. |
Rosenfeld et al. Primary care, clinics in office practice, vol. 23, pp. 677-685, 1996. |
Dagan et al. Ear, Nose and Throat Journal, vol. 77, pp. 16-19, Jun. 1998. |